For your doctor to analyze and report back to you.
Galantamine Slashes Heart Attacks and Death
A new study has found that subjects taking the highest recommended doses of cholinesterase inhibitors (ChEIs)—including donepezil (at 10 mg/day), rivastigmine (at 6 mg/day), and galantamine (at 24 mg/day)—had significantly lower levels of myocardial infarction (MI, aka heart attack) or significantly reduced risk of death from any cause.1 The research was conducted at Karolinska University Hospital, Stockholm, Sweden where over 7000 subjects (mean age 79 years) from the Swedish Dementia Registry with the diagnoses of Alzheimer’s dementia or Alzheimer’s mixed dementia since 2007 were followed for a mean period of 503 days. In the study, those who used ChEI, compared to those who did not, experienced:
- 38% lower risk of heart attack
- 26% lower risk of death from stroke and other cardiovascular diseases
- 36% lower risk of death from any cause
No comments:
Post a Comment